From Identification to Insight: Making Full Use of the Diagnostic Potential of MS/MS Proteotyping in Clinical Microbiology Using Efficient Bioinformatics

Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology...

Full description

Saved in:
Bibliographic Details
Published in:Journal of proteome research Vol. 24; no. 11; p. 5336
Main Authors: Muth, Thilo, Karlsson, Roger, Yu, Yi-Kuo, Alves, Gelio
Format: Journal Article
Language:English
Published: United States 07.11.2025
Subjects:
Bacteria - classification
Bacteria - isolation & purification
Computational Biology - methods
Humans
Proteomics - methods
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Tandem Mass Spectrometry - methods
AMR detection
diagnostic microbiology
mass spectrometry-based diagnostics
pathogen detection
clinical proteomics
taxonomic inference
proteotyping
bioinformatics workflows
ISSN:1535-3907, 1535-3907
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Accurate and rapid pathogen identification is critical for modern diagnostics, driving the need for technologies that combine speed, specificity, and functional insight. In this context, mass spectrometry (MS)-based proteomics is rapidly emerging as a transformative approach in clinical microbiology, offering comprehensive characterization of microorganisms and direct identification of protein biomarkers relevant to infectious disease diagnostics. While MS1-based approaches such as MALDI-TOF Biotyper have revolutionized species-level microbial identification through rapid and cost-effective workflows, they remain fundamentally limited in resolving strain-level differences and in detecting antimicrobial resistance (AMR) determinants. In contrast, so-called proteotyping enables the identification of organisms and resistance-associated proteins based on peptide sequence information obtained by tandem mass spectrometry (MS/MS), most commonly using shotgun proteomics. However, the clinical utility of proteotyping depends on the availability of efficient and accurate bioinformatics tools capable of handling large databases, disambiguating shared peptide sequences, and providing taxonomic and functional assignments with clinical relevance. This perspective highlights the diagnostic potential of MS/MS proteotyping and argues that advances in bioinformatics pipelines are needed for moving from microbial identification to actionable clinical insight.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1535-3907
1535-3907
DOI:10.1021/acs.jproteome.5c00733